Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00247156 · ClinicalTrials.gov registry record · Phase 1
An Autism Study Using Nambudripad's Food Allergy Elimination Treatments
A Phase 1 study of Autism and Food Allergies, sponsored by Nambudripad's Allergy Research Foundation.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT00247156 is a Phase 1 study of Autism and Food Allergies that has completed, run by Nambudripad's Allergy Research Foundation. The registered enrollment target is 60 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00247156, a Phase 1 study of Autism and Food Allergies, has completed, sponsored by Nambudripad's Allergy Research Foundation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
1\. We hypothesize that children in the experimental group will show a significant improvement over the control group as all food allergens groups and some other relevant allergenic substances are desensitized in a systematic way using the NAET® methodology within the specified period of study.
Conditions Studied
Interventions
- PROCEDURE Acupressure treatments and NAET treatments
Study Locations (1)
California
- PNIB Research Center - Buena Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2004-11 |
| Est. Completion | 2005-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00247156
The ClinicalTrials.gov registry entry for NCT00247156 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 104 other Autism trials with a reported enrollment target (67% lower). The listed sponsor is Nambudripad's Allergy Research Foundation, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Acupressure treatments and NAET treatments is the first listed.
NCT00247156 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00247156 about?
NCT00247156 is a clinical study titled "An Autism Study Using Nambudripad's Food Allergy Elimination Treatments". 1\. We hypothesize that children in the experimental group will show a significant improvement over the control group as all food allergens groups and some other relevant allergenic substances are desensitized in a systematic way using the NAET® methodology within the specified period of study.
What is the current status of trial NCT00247156?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2004-11. Estimated completion is 2005-11.
What conditions does trial NCT00247156 study?
This clinical trial studies the following conditions: Autism, Food Allergies.
What interventions are being tested in trial NCT00247156?
The interventions under investigation include: Acupressure treatments and NAET treatments (PROCEDURE).
Who is sponsoring clinical trial NCT00247156?
This trial is sponsored by Nambudripad's Allergy Research Foundation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00247156 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study
RECRUITING · Phase 1
-
Trichuris Suis Ova in Autism Spectrum Disorders
COMPLETED · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.